Anju Software Introduces AI Ecosystem for Rapid Clinical Trial Setup

Anju Software has introduced clinexa, an AI-driven ecosystem aimed at transforming clinical trial setups, announced in a press release. This innovative platform automates the conversion of clinical protocols into trial-ready databases, significantly reducing the time required from months to just days.

The initial release of clinexa focuses on automating protocol ingestion and generating essential trial components such as casebooks, edit checks, and validation materials. This automation is designed to accelerate the database creation and validation process, enabling sponsors and Contract Research Organizations (CROs) to launch trials more swiftly and concentrate on patient care.

Key benefits of clinexa include a 90% reduction in study build times, a 50% decrease in queries due to NLP-powered edit checks, and a threefold increase in productivity for data managers. The platform ensures data sovereignty, with Anju Software not monetizing customer data.

The introduction of clinexa addresses the costly and time-consuming nature of clinical trial startups, offering a critical edge in quality and compliance for life sciences organizations.